News

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...
Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...
The Tigers (22-13) took three of four from the Angels and head into Monday’s off-day with the AL's best record.
Why This Beef Stew Deserves A Spot In Your Weekly Rotation This isn’t your average beef stew—it’s a rich, creamy, ...
Utilizing a filamentous fungus in the gut microbiome may provide a new strategy for treating metabolic dysfunction-associated ...
I messed around and found out how these DIY food dish mash-up taste at New Orleans Jazz Fest. Here's the best of the bunch ...
This local sensation mashes up pop and rock hits with a full brass section, turning every show into a high-energy singalong.
A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.
A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...
Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...
Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...